Voyager Therapeutics Ownership | Who Owns Voyager Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Voyager Therapeutics Ownership Summary


Voyager Therapeutics is owned by 56.47% institutional investors, 16.55% insiders, and 26.98% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.77% of VYGR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.10% of its assets in Voyager Therapeutics shares.

VYGR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVoyager Therapeutics56.47%16.55%26.98%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.73M9.77%$17.83M
Blackrock5.31M9.30%$42.02M
Armistice capital4.80M8.18%$14.93M
Ecor1 capital3.92M6.77%$22.21M
Vanguard group3.22M5.56%$18.23M
Vestal point capital, lp1.48M2.51%$4.59M
Dimensional fund advisors lp1.38M2.39%$7.83M
Geode capital management1.08M1.87%$6.15M
State street900.93K1.56%$5.11M
Price t rowe associates inc /md/862.43K1.49%$4.89M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ecor1 capital3.92M0.84%$22.21M
Armistice capital4.80M0.26%$14.93M
Vestal point capital, lp1.48M0.24%$4.59M
Clarivest asset management102.82K0.08%$813.32K
Virtus fund advisers4.03K0.07%$22.85K
Hunter perkins capital management60.34K0.04%$188.00K
Patriot financial group insurance agency121.10K0.04%$376.62K
Adar1 capital management79.94K0.04%$248.63K
Ikarian capital55.77K0.03%$173.43K
Fiduciary trust259.40K0.01%$806.73K

Top Buyers

HolderShares% AssetsChange
Blackrock5.31M0.00%915.17K
Blackrock funding, inc. /de5.73M0.00%319.51K
Bank of america corp /de/648.76K0.00%294.32K
Dimensional fund advisors lp1.38M0.00%275.57K
Vestal point capital, lp1.48M0.24%225.58K

Top Sellers

HolderShares% AssetsChange
Farallon capital management715.00K0.01%-1.86M
Armistice capital4.80M0.26%-636.00K
Great point partners---626.27K
Federated hermes---551.40K
Prudential financial---330.30K

New Positions

HolderShares% AssetsChangeValue
Ethic41.42K0.00%41.42K$122.59K
Occudo quantitative strategies lp25.00K0.01%25.00K$77.74K
State of wisconsin investment board21.62K0.00%21.62K$67.23K
Los angeles capital management16.18K0.00%16.18K$50.32K
Nverses capital100.000.00%100.00$791.00

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Capital performance advisors llp-16.00
Ifp advisors-25.00
Rothschild investment-30.00
Pnc financial services group-30.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025109-6.03%33,129,2617.64%562.03%45-2.17%33-21.43%
Mar 31, 2025116-12.12%34,619,8870.33%591.67%46-32.35%4216.67%
Dec 31, 2024131-0.76%34,504,533-1.80%591.62%6715.52%36-
Sep 30, 20241321.54%35,137,594-5.22%601.47%58-12.12%37-7.50%
Jun 30, 2024129-4.44%37,074,4377.46%641.01%66-26.67%3939.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.71M3.10%-
Vanguard Total Stock Mkt Idx Inv1.68M3.02%-36.97K
iShares Russell 2000 ETF1.12M2.01%-21.21K
Vanguard Institutional Extnd Mkt Idx Tr474.33K0.86%-193.13K
Fidelity Small Cap Index464.54K0.84%-7.05K
Vanguard Explorer Inv457.06K0.83%-
BlackRock Health Sciences Opps Inv A425.92K0.77%-
iShares Russell 2000 Value ETF404.70K0.73%300.00
BlackRock Health Sciences Term Trust363.32K0.66%-
T. Rowe Price Health Sciences350.45K0.63%-13.20K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 18, 2025Ferguson Toby Chief Medical OfficerSell$70.87K
Apr 02, 2025Ferguson Toby Chief Medical OfficerSell$34.59K
Apr 02, 2025Sandrock Alfred President and CEOSell$37.34K
Feb 20, 2025Carter Todd Alfred Chief Scientific OfficerSell$14.08K
Feb 20, 2025Sandrock Alfred President and CEOSell$49.62K

Insider Transactions Trends


DateBuySell
2025 Q3-1
2025 Q2-2
2025 Q1-9
2024 Q4-2
2024 Q3--

VYGR Ownership FAQ


Who Owns Voyager Therapeutics?

Voyager Therapeutics shareholders are primarily institutional investors at 56.47%, followed by 16.55% insiders and 26.98% retail investors. The average institutional ownership in Voyager Therapeutics's industry, Biotech Stocks , is 304.14%, which Voyager Therapeutics falls below.

Who owns the most shares of Voyager Therapeutics?

Voyager Therapeutics’s largest shareholders are Blackrock funding, inc. /de (5.73M shares, 9.77%), Blackrock (5.31M shares, 9.30%), and Armistice capital (4.8M shares, 8.18%). Together, they hold 27.25% of Voyager Therapeutics’s total shares outstanding.

Does Blackrock own Voyager Therapeutics?

Yes, BlackRock owns 9.30% of Voyager Therapeutics, totaling 5.31M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.02M$. In the last quarter, BlackRock increased its holdings by 915.17K shares, a 20.81% change.

Who is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested?

Ecor1 capital is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.84% of its assets in 3.92M Voyager Therapeutics shares, valued at 22.21M$.

Who is the top mutual fund holder of Voyager Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Voyager Therapeutics shares, with 3.10% of its total shares outstanding invested in 1.71M Voyager Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools